N
N. Sarita Shah
Researcher at Centers for Disease Control and Prevention
Publications - 41
Citations - 1979
N. Sarita Shah is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Tuberculosis & Extensively drug-resistant tuberculosis. The author has an hindex of 14, co-authored 41 publications receiving 1709 citations. Previous affiliations of N. Sarita Shah include Emory University & Albert Einstein College of Medicine.
Papers
More filters
Journal ArticleDOI
Worldwide Emergence of Extensively Drug-resistant Tuberculosis
N. Sarita Shah,Abigail Wright,Gill-Han Bai,Lucía Barrera,Fadila Boulahbal,Nuria Martín-Casabona,Francis Drobniewski,Chris Gilpin,Marta Havelková,Rosario Lepe,Richard Lumb,Beverly Metchock,Françoise Portaels,Maria Filomena Rodrigues,Sabine Rüsch-Gerdes,Armand Van Deun,Véronique Vincent,Kayla F. Laserson,Charles D. Wells,J. Peter Cegielski +19 more
TL;DR: Mycobacterium tuberculosis strains are becoming resistant to not only the most powerful first- line drugs but also many second-line drugs.
Journal ArticleDOI
HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.
Neel R. Gandhi,N. Sarita Shah,Jason R. Andrews,Venanzio Vella,Anthony P. Moll,Michelle Scott,Darren Weissman,Claudio Marra,Umesh G. Lalloo,Gerald Friedland +9 more
TL;DR: Mortality from MDR and XDR TB in this high HIV-prevalence region is extraordinarily high, particularly within the first 30 days, and efforts to reduce mortality must focus on earlier diagnosis and early initiation of second-line TB and antiretroviral therapy.
Journal ArticleDOI
Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.
N. Sarita Shah,N. Sarita Shah,N. Sarita Shah,Sara C. Auld,James C.M. Brust,Barun Mathema,Nazir Ahmed Ismail,Pravi Moodley,Koleka Mlisana,Salim Allana,Angela Campbell,Thuli Mthiyane,Natashia Morris,Primrose Mpangase,Hermina van der Meulen,Shaheed V. Omar,Tyler S. Brown,Apurva Narechania,Elena Shaskina,Thandi Kapwata,Barry N. Kreiswirth,Neel R. Gandhi,Neel R. Gandhi +22 more
TL;DR: The majority of cases of XDR tuberculosis in KwaZulu‐Natal, South Africa, an area with a high tuberculosis burden, were probably due to transmission rather than to inadequate treatment of MDR tuberculosis, suggesting control of the epidemic of drug‐resistant tuberculosis requires an increased focus on interrupting transmission.
Journal ArticleDOI
What We Know About Tuberculosis Transmission: An Overview.
Gavin J. Churchyard,Peter S. Kim,N. Sarita Shah,Roxana Rustomjee,Neel R. Gandhi,Barun Mathema,David W. Dowdy,Anne G. Kasmar,Vicky Cárdenas +8 more
TL;DR: A high-level overview of what is known about tuberculosis transmission is provided, using the tuberculosis transmission cascade as a framework, and to set the scene for the articles in this series, which address specific aspects of tuberculosis transmission.
Journal ArticleDOI
Extensively drug-resistant tuberculosis in the United States, 1993-2007.
N. Sarita Shah,Robert H. Pratt,Lori R. Armstrong,Valerie A. Robison,Kenneth G. Castro,J. Peter Cegielski +5 more
TL;DR: The number of extensively drug-resistant tuberculosis cases in the United States has declined since 1993, coinciding with improved TB and HIV/AIDS control, and cases continue to be reported each year.